On Monday, March 30, Rush Limbaugh read an excerpt from a Wall Street Journal op-ed by Dr. Jeff Colyer describing his experience treating COVID-19 patients in Kansas City with a combination of hydroxychloroquine and azithromycin. “In the fight against Covid-19 though we might look forward in doom, one day we will look backward […]
Author: Erik Sass
Steve Forbes on the latest trends — new COVID-19 tests and treatment
There is growing interest in a drug usually prescribed for malaria or lupus, hydroxychloroquine, as a potential treatment for the COVID-19/novel coronavirus now circling the globe. In recent weeks doctors in Kansas City have reported positive results with hydroxychloroquine in conjunction with azithromycin (often called Z-Pak). These promising findings come on the heels of […]
The Reality of Obamacare and Consumer Sovereignty
By Aaron Morrison, American Consumer Institute Earlier this year, the Supreme Court decided that they will hear the most recent challenge to the Affordable Care Act (ACA). The challenge, now referred to as California v. Texas, calls on the Supreme Court to repeal the ACA. Yet, simply repealing the ACA […]
Alaska can’t afford an income tax!
The price war begun by Saudi Arabia and Russia is claiming more collateral damage, including the finances of the state of Alaska (which decades after peak production in the 1980s still pumps around 500,000 barrels per day). The financial crunch is prompting some Alaskan lawmakers to consider imposing a state income tax […]
Don’t get VD (viral disinformation)
Writing for Business Insider, health policy communications thought leader Jove Oliver warns that in addition to the deadly threat of the virus, we face a related threat in the form of the cloud of disinformation and fake news emanating from obscure sources around the Internet. This misinformation can have deadly consequences itself, […]
WSJ: Combination treatment for COVID-19 continues to show promise
Dr. Jeff Colyer is back with another piece in the Wall Street Journal providing an update on COVID-19 patients being treated with a combination of the drugs hydroxychloroquine (HC) and azithromycin (more commonly known as Z-Pak). Newly emerging data are showing more potential promise that COVID-19 can be treated with these medicines, with patients […]
No Time to Undermine R&D Partnerships
The outcome of the world’s response to COVID-19 depends largely on the success of longstanding research and development (R&D) partnerships between public and private sector institutions, including national governments, universities, and pharmaceutical companies. So it’s crucial that governments resist the impulse to undermine these relationships by adopting policies inimical to private sector research […]
Can AI help fight COVID-19?
“Artificial intelligence in the fight against COVID-19” By Georgios Petropoulos, courtesy of the Bruegel Institute In the face of the coronavirus, digital technologies are vital for both social health and economic performance. A digital response to the COVID-19 pandemic can take multiple forms and bring significant value. One important area in which […]
Copper-infused textiles can fight coronavirus — and future pandemics
“Materials Science Revolution Vs. Coronavirus: Copper-Infusion to Turn Common Cotton Fibers Into a ‘Defensive Wall’?” By Sandra Wirtz, courtesy of American Resources Policy Network Last week, we discussed the antimicrobial properties of copper, the re-introduction of which experts argue could help the fight against Coronavirus and future pandemics — particularly in hospitals and other public […]
Dr. Jeff Colyer: Combo of existing drugs shows promise against COVID-19
It’s no exaggeration to say that the fate of the world, or at least the global economy, appears to hang on the possibility of scientists and doctors creating a vaccine for COVID-19 and either producing new drugs or — more realistically for the urgent needs of the present — discovering effective treatments among […]